首页> 外国专利> Treatment of osteoporosis in peri- and post-menopausal women with hepcidin

Treatment of osteoporosis in peri- and post-menopausal women with hepcidin

机译:Hepcidin治疗绝经前后妇女骨质疏松症

摘要

The present invention is directed to a method of treating, preventing, or reducing the risk of bone deterioration or osteoporosis in a peri- or post-menopausal female subject. The method involves selecting a peri- or post-menopausal female subject in need of treating, preventing, or reducing the risk of bone deterioration or osteoporosis and administering hepcidin to the selected subject under conditions effective to treat, prevent, or reduce the risk of bone deterioration or osteoporosis.
机译:本发明涉及一种治疗,预防或减少绝经前后女性受试者中骨质退化或骨质疏松症的风险的方法。该方法包括选择需要治疗,预防或降低骨变质或骨质疏松风险的围绝经期或绝经后女性受试者,并在有效治疗,预防或降低骨风险的条件下向所选受试者施用铁调素。恶化或骨质疏松。

著录项

  • 公开/公告号US8999935B2

    专利类型

  • 公开/公告日2015-04-07

    原文格式PDF

  • 申请/专利权人 XI HUANG;

    申请/专利号US20100704187

  • 发明设计人 XI HUANG;

    申请日2010-02-11

  • 分类号A61K38/16;A61K38/17;A61K38/22;A61P19/08;A61P19/10;C07K14/575;A61K31/711;

  • 国家 US

  • 入库时间 2022-08-21 15:17:05

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号